Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Turtle Cameron
Over the trailing 90 days, Turtle Cameron (Director at Spyre Therapeutics, Inc.) sold $2.4M of stock in SYRE, per 6 SEC Form 4 transactions.
- Role
- Director
- Companies
- SYRE
- Window
- Trailing 90 days · 6 transactions · CIK 1758363
- Net activity
- −$2.4M ($0 bought · $2.4M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 6 | — | $2.4M | −$2.4M |
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-01 | SYRE | Sell | 10.2K | $890K | Open market or private sale |
| 2026-07-01 | SYRE | Sell | 590 | $52K | Open market or private sale |
| 2026-07-01 | SYRE | Sell | 4.2K | $373K | Open market or private sale |
| 2026-06-01 | SYRE | Sell | 3.3K | $235K | Open market or private sale |
| 2026-06-01 | SYRE | Sell | 8.1K | $575K | Open market or private sale |
| 2026-06-01 | SYRE | Sell | 3.6K | $247K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Turtle's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.